Annual CFF
$22.70 M
+$22.49 M+10864.73%
31 December 2023
Summary:
Neuronetics annual cash flow from financing activities is currently $22.70 million, with the most recent change of +$22.49 million (+10864.73%) on 31 December 2023. During the last 3 years, it has risen by +$20.33 million (+858.08%). STIM annual CFF is now -76.61% below its all-time high of $97.04 million, reached on 31 December 2018.STIM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$16.37 M
-$16.37 M-100.00%
30 September 2024
Summary:
Neuronetics quarterly cash flow from financing activities is currently -$16.37 million, with the most recent change of -$16.37 million (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$16.37 million (-100.00%). STIM quarterly CFF is now -116.83% below its all-time high of $97.27 million, reached on 30 September 2018.STIM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$5.89 M
-$16.37 M-73.55%
30 September 2024
Summary:
Neuronetics TTM cash flow from financing activities is currently $5.89 million, with the most recent change of -$16.37 million (-73.55%) on 30 September 2024. Over the past year, it has increased by +$5.21 million (+763.34%). STIM TTM CFF is now -94.20% below its all-time high of $101.58 million, reached on 30 September 2018.STIM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STIM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -100.0% | +763.3% |
| 3 y3 years | +858.1% | -10000.0% | -92.9% |
| 5 y5 years | -76.6% | -3795.7% | +111.8% |
STIM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -72.7% | >+9999.0% | -173.6% | at low | -92.9% | >+9999.0% |
| 5 y | 5 years | -76.6% | >+9999.0% | -119.9% | at low | -92.9% | >+9999.0% |
| alltime | all time | -76.6% | >+9999.0% | -116.8% | at low | -94.2% | >+9999.0% |
Neuronetics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.37 M(<-9900.0%) | $5.89 M(-73.5%) |
| June 2024 | - | $0.00(0.0%) | $22.26 M(+0.3%) |
| Mar 2024 | - | $0.00(-100.0%) | $22.20 M(-2.2%) |
| Dec 2023 | $22.70 M(>+9900.0%) | $22.26 M(>+9900.0%) | $22.70 M(+3228.0%) |
| Sept 2023 | - | $0.00(-100.0%) | $682.00 K(0.0%) |
| June 2023 | - | -$62.00 K(-112.4%) | $682.00 K(-9.5%) |
| Mar 2023 | - | $499.00 K(+103.7%) | $754.00 K(+264.3%) |
| Dec 2022 | $207.00 K(-99.8%) | $245.00 K(>+9900.0%) | $207.00 K(-3550.0%) |
| Sept 2022 | - | $0.00(-100.0%) | -$6000.00(-106.4%) |
| June 2022 | - | $10.00 K(-120.8%) | $94.00 K(-88.2%) |
| Mar 2022 | - | -$48.00 K(-250.0%) | $795.00 K(-99.0%) |
| Dec 2021 | $83.01 M(+3403.8%) | $32.00 K(-68.0%) | $83.01 M(-0.0%) |
| Sept 2021 | - | $100.00 K(-85.9%) | $83.03 M(-0.4%) |
| June 2021 | - | $711.00 K(-99.1%) | $83.34 M(+0.8%) |
| Mar 2021 | - | $82.16 M(>+9900.0%) | $82.68 M(+3390.0%) |
| Dec 2020 | $2.37 M | $56.00 K(-86.3%) | $2.37 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $410.00 K(+754.2%) | $2.41 M(-1.3%) |
| June 2020 | - | $48.00 K(-97.4%) | $2.45 M(-14.7%) |
| Mar 2020 | - | $1.85 M(+1755.0%) | $2.87 M(+18.5%) |
| Dec 2019 | $2.42 M(-97.5%) | $100.00 K(-77.4%) | $2.42 M(-12.9%) |
| Sept 2019 | - | $443.00 K(-5.7%) | $2.78 M(-97.2%) |
| June 2019 | - | $470.00 K(-66.6%) | $99.61 M(+1.0%) |
| Mar 2019 | - | $1.41 M(+205.9%) | $98.64 M(+1.7%) |
| Dec 2018 | $97.04 M(+307.0%) | $460.00 K(-99.5%) | $97.04 M(-4.5%) |
| Sept 2018 | - | $97.27 M(<-9900.0%) | $101.58 M(+2248.2%) |
| June 2018 | - | -$494.00 K(+148.2%) | $4.33 M(-78.0%) |
| Mar 2018 | - | -$199.00 K(-104.0%) | $19.66 M(-17.5%) |
| Dec 2017 | $23.84 M(+387.0%) | $5.00 M(>+9900.0%) | $23.84 M(+26.6%) |
| Sept 2017 | - | $14.00 K(-99.9%) | $18.84 M(+0.1%) |
| June 2017 | - | $14.84 M(+272.4%) | $18.83 M(+372.4%) |
| Mar 2017 | - | $3.98 M | $3.98 M |
| Dec 2016 | $4.90 M | - | - |
FAQ
- What is Neuronetics annual cash flow from financing activities?
- What is the all time high annual CFF for Neuronetics?
- What is Neuronetics annual CFF year-on-year change?
- What is Neuronetics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Neuronetics?
- What is Neuronetics quarterly CFF year-on-year change?
- What is Neuronetics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Neuronetics?
- What is Neuronetics TTM CFF year-on-year change?
What is Neuronetics annual cash flow from financing activities?
The current annual CFF of STIM is $22.70 M
What is the all time high annual CFF for Neuronetics?
Neuronetics all-time high annual cash flow from financing activities is $97.04 M
What is Neuronetics annual CFF year-on-year change?
Over the past year, STIM annual cash flow from financing activities has changed by +$22.49 M (+10864.73%)
What is Neuronetics quarterly cash flow from financing activities?
The current quarterly CFF of STIM is -$16.37 M
What is the all time high quarterly CFF for Neuronetics?
Neuronetics all-time high quarterly cash flow from financing activities is $97.27 M
What is Neuronetics quarterly CFF year-on-year change?
Over the past year, STIM quarterly cash flow from financing activities has changed by -$16.37 M (-100.00%)
What is Neuronetics TTM cash flow from financing activities?
The current TTM CFF of STIM is $5.89 M
What is the all time high TTM CFF for Neuronetics?
Neuronetics all-time high TTM cash flow from financing activities is $101.58 M
What is Neuronetics TTM CFF year-on-year change?
Over the past year, STIM TTM cash flow from financing activities has changed by +$5.21 M (+763.34%)